Should prophylactic granulocyte-colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide-based therapy?
about
Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myelomaIntermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone.Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia.Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma.Lenalidomide and its role in the management of multiple myeloma.Current multiple myeloma treatment strategies with novel agents: a European perspectiveOptimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement.Guidelines for supportive care in multiple myeloma 2011.Limiting early mortality: Do's and don'ts in the management of patients with newly diagnosed multiple myeloma.An international, multicenter, prospective, observational study of neutropenia in patients being treated with lenalidomide + dexamethasone for relapsed or relapsed/refractory multiple myeloma (RR-MM).
P2860
Q33413142-A010EC07-FFC3-4695-B631-E16BFB902662Q33414647-3478855A-B1C4-4B14-AA56-8522B105AF20Q34009041-06827C73-3A82-4C73-86FB-31664A842E35Q36065299-239D03A2-F1E6-4F18-8ACE-44631F1E8A14Q37183439-87ECD9D3-78F9-4FBD-9AB8-5A5E8FB50993Q37677935-269F1DFF-7175-4155-92D8-FC335018BB7CQ37835695-C1B78A85-4DD7-4E4B-BD84-D6F5AB67E961Q37868637-3364C8A1-398A-40D5-9BEE-F9466229BF3DQ38555091-278A063A-89C2-4CDB-BDBC-493A0BB27E0BQ48808489-76E93B82-4061-4ABC-BCDE-29D1F9417247
P2860
Should prophylactic granulocyte-colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide-based therapy?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Should prophylactic granulocyt ...... er lenalidomide-based therapy?
@en
Should prophylactic granulocyt ...... er lenalidomide-based therapy?
@nl
type
label
Should prophylactic granulocyt ...... er lenalidomide-based therapy?
@en
Should prophylactic granulocyt ...... er lenalidomide-based therapy?
@nl
prefLabel
Should prophylactic granulocyt ...... er lenalidomide-based therapy?
@en
Should prophylactic granulocyt ...... er lenalidomide-based therapy?
@nl
P2860
P50
P1476
Should prophylactic granulocyt ...... er lenalidomide-based therapy?
@en
P2093
Juan Olazábal
María-Victoria Mateos
P2860
P304
P356
10.1111/J.1365-2141.2007.06946.X
P407
P577
2007-12-07T00:00:00Z